This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Moderna (MRNA) Amends Coronavirus Vaccine Supply Deal in U.K.
by Zacks Equity Research
Moderna (MRNA) amends its present contract with the United Kingdom government to supply two million additional doses of its coronavirus vaccine candidate, mRNA-1273, upon approval.
Moderna (MRNA) Takes to Lead in Covid Sweepstakes
by Mark Vickery
Overall efficacy has reached 94.1%, with treatment of severe cases of Covid proving 100% effective.
Stock Market News for Nov 30, 2020
by Zacks Equity Research
U.S. stock markets closed higher on Friday amid optimism surrounding COVID-19 vaccine.
5 of the Best Stocks to Buy Heading Into December
by Tirthankar Chakraborty
Progress toward a COVID-19 vaccine and Yellen likely to be selected for a top post certainly bode well for stocks in December. Some of the stocks worth investing in are Buckle (BKE) and Deere (DE).
Biotech ETF (XBI) Hits New 52-Week High
by Sanghamitra Saha
The biotech ETF hits a 52-week high on Nov 27. Can it soar further?
Stocks Continue to Climb Amid More Positive Vaccine Trial Results
by David Borun
The major indices all gain between 2 and 3% as hopes for an effective Covid-19 vaccine promise a "return to normal."
Top Research Reports for Amazon, Alphabet & Zoom Video
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Alphabet Inc. (GOOGL) and Zoom Video Communications, Inc. (ZM).
Markets Gear for a Different Black Friday
by Zacks Equity Research
Markets Gear for a Different Black Friday
Energy on Track for Its Best Month Ever: 5 ETF, Stock Winners
by Sweta Killa
The S&P 500 Energy Index is on track for the best month ever, gaining nearly 40%.
Stock Market News for Nov 27, 2020
by Zacks Equity Research
The Dow and the S&P 500 closed in the red on Wednesday after rise in weekly jobless claims underscored that the recovery in labor market is slowing, as well as a surge in new coronavirus cases.
Black Friday 2020 Has a New Look
by Mark Vickery
$10.3 billion in Black Friday revenues are expected online today, growing 33% year over year.
Equinor (EQNR) Jumps 26.1% MTD: What's Driving the Rally?
by Zacks Equity Research
Improving oil prices on encouraging coronavirus vaccine news aid Equinor (EQNR).
4 Consumer Discretionary Gainers From Positive Vaccine News
by Zacks Equity Research
Positive vaccine news along with a steady rise in consumer spending bode well for discretionary stocks, making it a good time to invest in names like Malibu Boats (MBUU) and YETI Holdings (YETI).
Moderna (MRNA) Inks Europe Supply Deal for COVID-19 Vaccine
by Zacks Equity Research
Moderna (MRNA) signs a deal to supply up to 160 million vaccine doses to European Commission The vaccine is under review in Europe.
UPS Soars 71.1% in the Past 6 Months: More Room for Rally?
by Zacks Equity Research
The surge in e-commerce demand in the current pandemic scenario bodes well for the UPS stock.
BP Jumps 38.3% Month To Date: What's Driving the Rally?
by Zacks Equity Research
Improving oil prices on encouraging coronavirus vaccine news aid BP plc (BP).
Wall Street Set to Close the Year Higher: 5 Top Growth Picks
by Zacks Equity Research
The stock market is poised to close the year positively, driven by a flurry of encouraging developments, making it a good time to invest in growth stocks like Beazer Homes (BZH) and Axcelis (ACLS).
Stock Market News for Nov 25, 2020
by Zacks Equity Research
The Dow crossed the 30,000 points mark on Tuesday as investors hoped for a swift economic recovery following progress in coronavirus vaccine development and transition of President-elect Joe Biden to the White House.
Dow Tops 30,000: 5 Stocks Driving the ETF
by Sweta Killa
The Dow Jones topped the 30,000 milestone for the first time on vaccine optimism, and improving prospects for the smooth transition of President-elect Joe Biden to White House.
Small-Cap ETF (DWAS) Hits New 52-Week High
by Sweta Killa
This small-cap ETF hits a new 52-week high. Are more gains in store for this ETF?
3 mREIT Stocks to Buy Amid Vaccine Hopes & Thanksgiving Cheer
by Devyani Chamria
The overall optimism in the market, thanks to the positive news on the vaccine front and strong rebound in the economy creates a favorable backdrop for mortgage REITs like AGNC, NLY, and RC.
Vaccine News Propels Market Higher: 5 Potential Gainers
by Zacks Equity Research
Promising vaccine news aided the market in moving higher with further economic recovery in sight, making it a good time to invest in fundamentally sound names like EnPro (NPO) and APi Group (APG).
Thanksgiving Brings Strong Seasonal Market Trends: 5 Picks
by Tirthankar Chakraborty
Traditionally, the stock market tends to perform well from the Thanksgiving week till the end of the year. This calls for investing in growth stocks like General Motors (GM) & Malibu Boats (MBUU).
Permian Producers in Focus as Crude Price Picks Up
by Nilanjan Banerjee
Improving oil prices are definitely a boon for Permian explorers like Devon (DVN), Diamondback (FANG), Concho (CXO) and Matador (MTDR).
ETFs to Play as Vaccine News Looks to Outdo Virus Fear
by Sanghamitra Saha
After almost a year-long wait, the month of November started delivering sweet surprises to investors in the form of back-to-back vaccine news.